Xenon Pharmaceuticals
XENE
#3533
Rank
A$4.56 B
Marketcap
$58.73
Share price
-1.52%
Change (1 day)
-10.25%
Change (1 year)

Earnings for Xenon Pharmaceuticals (XENE)

Earnings in 2024 (TTM): -A$0.43 Billion

According to Xenon Pharmaceuticals's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -A$0.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Xenon Pharmaceuticals from 2014 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.44 Billion30.48%
2023 -A$0.34 Billion70.89%
2022 -A$0.2 Billion58.08%
2021 -A$0.13 Billion176.95%
2020 -A$44.67 Million-28.8%
2019 -A$62.74 Million21.38%
2018 -A$51.69 Million4.53%
2017 -A$49.45 Million27.63%
2016 -A$38.75 Million165.11%
2015 -A$14.62 Million-176.14%
2014 A$19.19 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$86.89 M-119.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.13 Billion-71.07%๐Ÿ‡บ๐Ÿ‡ธ USA